Category Archives: Thyroid and Parkinsons

Thyroid function and autoimmunity in Parkinson’s disease: a study of 101 patients.

Posted on by

Thyroid function and autoimmunity in Parkinson’s disease: a study of 101 patients.

Bonuccelli U, D’Avino C, Caraccio N, Del Guerra P, Casolaro A, Pavese N, Del Dotto P, Monzani F.

Source

Department of Neuroscience, Section of Neurology (U.B., C.D.A., N.P., P.D.D.), University of Pisa, Via Roma, 67 I-56126 Pisa, Italy.

Abstract

Thyroid disease is the endocrine dysfunction most frequently reported in association with idiopathic Parkinson’s disease (PD). The aim of this study was to assess thyroid autoimmunity and function in PD, and to verify the effect of long term l-dopa and/or dopamine therapy on thyroid function. We studied 101 consecutive PD outpatients and seventy age- and sex-matched neurological non-PD patients as controls. They were evaluated for free thyroid hormones, TSH and thyroid autoantibodies. No significant difference in the prevalence of thyroid autoimmunity and dysfunction was found between PD patients and neurological controls (10.8% in PD patients vs 10% in neurological controls). Further, treatment with l-dopa and/or dopaminergic drugs and the stage of Parkinson’s disease did not affect thyroid function. In conclusion, the prevalence of thyroid autoimmunity in PD patients appeared similar to that as described in the general population, though thyroid dysfunction was observed in over than 10% of PD patients. Indeed, neurologists should be alerted to the possible complications arising from thyroid dysfunction in Parkinson’s disease, but thyroid function tests should be performed only when justified on clinical grounds.

Comment:

Glutathione helps down regulate the inflammatory wind up that leads to autoimmunity. GlutaGenic offers the only absorbable and high potency Glutathione on the market.

Thyroid and Dopamine Levels. Hypothyroidism and Parkinson’s Disease.

Posted on by

Hypothyroidism and Parkinson’s Disease

Abstract

Although it is commonly recognised that diseases of the thyroids can simulate extrapyramidal disorders, a review of the causes of Parkinsonism in the neurology literature shows that they are not usually mentioned or, if so, only very briefly. The development of hypothyroidism in a patient with Parkinson s disease can go undetected, since the course of both diseases can involve similar clinical features. Generally speaking there is always an insistence on the need to conduct a thyroidal hormone study in any patient with symptoms of Parkinson, but no emphasis is put on the need to continue to rule out dysthyroidism throughout the natural course of the disease, in spite of the fact that the concurrence of both pathological conditions can be high and that, in the same way hypothyroidism can simulate Parkinson s disease, the latter can also conceal hypothyroidism.

CASE REPORT:

We report the case of a female patient who had been suffering from Parkinson s disease for 17 years and started to present on off fluctuations that did not respond to therapy. Hypothyroidism was observed and the hormone replacement therapy used to resolve the problem allowed the Parkinsonian fluctuations to be controlled.

CONCLUSIONS:

We believe that it is very wise to suspect hypothyroidism in patients known to be suffering from Parkinson s disease, and especially so in cases where the clinical condition worsens and symptoms no longer respond properly to antiparkinsonian treatment. These observations stress the possible role played by thyroid hormones in dopaminergic metabolism and vice versa.